Related Experiment Video

Updated: Dec 11, 2025

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.0K

Drive-Through Model for Anticoagulation Clinics During the COVID-19 Pandemic

Kaveh Rezaei Bookani1,2,3, Iva Minga2,4,3, Manisha Chander5

  • 1Division of Cardiovascular Medicine, Department of Medicine, Northshore University Health System, Evanston, IL, USA.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|August 22, 2020
PubMed

Insights

To ensure continuity of care during the COVID-19 pandemic, a novel drive-through anticoagulation clinic was established. This initiative maintained essential patient monitoring while adhering to social distancing guidelines.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • The COVID-19 pandemic created significant challenges for healthcare delivery, particularly for patients requiring chronic anticoagulation.
  • Patients with conditions like atrial fibrillation, venous thromboembolism, or valvular heart disease depend on regular monitoring at anticoagulation clinics.
  • Social distancing measures mandated during the pandemic threatened access to these essential healthcare services.

Purpose of the Study:

  • To describe the implementation of a drive-through anticoagulation clinic.
  • To ensure the continuation of care for patients on chronic anticoagulation therapy during the COVID-19 pandemic.
  • To provide a model for other clinics to adapt during public health crises.

Main Methods:

  • A drive-through clinic model was designed and implemented to facilitate safe patient access.
  • The clinic prioritized social distancing and isolation precautions.
  • Standard anticoagulation management protocols were adapted for the drive-through setting.

Main Results:

  • The drive-through clinic successfully provided continuous care to patients on chronic anticoagulation.
  • The initiative effectively maintained social distancing, mitigating COVID-19 transmission risks.
  • The model proved adaptable for ongoing anticoagulation management during a pandemic.

Conclusions:

  • Drive-through anticoagulation clinics are a viable solution for maintaining patient care during pandemics.
  • This innovative approach ensures the safety of both patients and healthcare providers.
  • The described model offers a scalable strategy for healthcare continuity during public health emergencies.

Keywords:
COVID-19anticoagulationdrive-through clinic

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.2K

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
179
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
562
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
242
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
940